GAMBIA
GAMBIA
FDA import refusal data for products from GAMBIA
Common Violations
Top Firms
| # | Firm Name | Risk | Refusals |
|---|---|---|---|
| 1 | Abacous Ltd. Banjul | Risk: 40.2 | 22 |
| 2 | DEGGEH FOODS INTERNATIONAL Serrekunda | Risk: 36.0 | 13 |
| 3 | Risk: 51.3 | 12 | |
| 4 | Gamex Enterprise Sere Kunda | Risk: 44.0 | 4 |
| 5 | Abacous Group Banjul | Risk: 49.7 | 3 |
| 6 | Bintou Macauley Bundung | Risk: 35.3 | 2 |
| 7 | Risk: 44.3 | 1 | |
| 8 | Medical Research Council Fatara | Risk: 32.3 | 1 |
| 9 | MS NOUR ALLAGA Banjul | Risk: 40.3 | 1 |
Frequently Asked Questions
How many FDA import refusals are from GAMBIA?
According to FDA records, there have been 59 import refusals for products originating from GAMBIA, involving 9 firms.
What products from GAMBIA are commonly refused by the FDA?
Products from GAMBIA may be refused for various reasons including adulteration, misbranding, lack of proper registration, or failure to meet U.S. safety standards. The specific products vary by firm and time period. View the common violations section on this page for more details.
Does an import refusal mean products from GAMBIA are unsafe?
Not necessarily. An import refusal indicates a specific shipment appeared to violate FDA requirements at the time of inspection. Many GAMBIA firms successfully import products that meet all FDA requirements. Import refusals help identify and prevent non-compliant products from entering the U.S. market.
How current is the FDA import refusal data for GAMBIA?
Our database includes FDA import refusals for GAMBIA through 8/27/2021. Data is sourced from the FDA Data Dashboard and updated monthly.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.